nodes	percent_of_prediction	percent_of_DWPC	metapath
Vildagliptin—Hepatitis—Mycophenolic acid—psoriasis	0.00248	0.00248	CcSEcCtD
Vildagliptin—Pancreatitis—Cyclosporine—psoriasis	0.00245	0.00245	CcSEcCtD
Vildagliptin—Oedema peripheral—Mycophenolic acid—psoriasis	0.00244	0.00244	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Acitretin—psoriasis	0.00244	0.00244	CcSEcCtD
Vildagliptin—Connective tissue disorder—Mycophenolic acid—psoriasis	0.00243	0.00243	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Fluocinolone Acetonide—psoriasis	0.00243	0.00243	CcSEcCtD
Vildagliptin—Pancreatitis—Mycophenolate mofetil—psoriasis	0.00239	0.00239	CcSEcCtD
Vildagliptin—Urticaria—Calcitriol—psoriasis	0.00239	0.00239	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Cyclosporine—psoriasis	0.00233	0.00233	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Acitretin—psoriasis	0.00231	0.00231	CcSEcCtD
Vildagliptin—Fatigue—Acitretin—psoriasis	0.00231	0.00231	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Fluocinolone Acetonide—psoriasis	0.0023	0.0023	CcSEcCtD
Vildagliptin—Dermatitis bullous—Betamethasone—psoriasis	0.0023	0.0023	CcSEcCtD
Vildagliptin—Dermatitis bullous—Dexamethasone—psoriasis	0.0023	0.0023	CcSEcCtD
Vildagliptin—Constipation—Acitretin—psoriasis	0.00229	0.00229	CcSEcCtD
Vildagliptin—Weight increased—Cyclosporine—psoriasis	0.00228	0.00228	CcSEcCtD
Vildagliptin—Angiopathy—Mycophenolic acid—psoriasis	0.00225	0.00225	CcSEcCtD
Vildagliptin—Pancreatitis—Prednisolone—psoriasis	0.00223	0.00223	CcSEcCtD
Vildagliptin—Infestation NOS—Cyclosporine—psoriasis	0.00223	0.00223	CcSEcCtD
Vildagliptin—Infestation—Cyclosporine—psoriasis	0.00223	0.00223	CcSEcCtD
Vildagliptin—Dizziness—Methoxsalen—psoriasis	0.00223	0.00223	CcSEcCtD
Vildagliptin—Weight increased—Mycophenolate mofetil—psoriasis	0.00222	0.00222	CcSEcCtD
Vildagliptin—Chills—Mycophenolic acid—psoriasis	0.00222	0.00222	CcSEcCtD
Vildagliptin—Pancreatitis—Hydrocortisone—psoriasis	0.00218	0.00218	CcSEcCtD
Vildagliptin—Infestation NOS—Mycophenolate mofetil—psoriasis	0.00218	0.00218	CcSEcCtD
Vildagliptin—Infestation—Mycophenolate mofetil—psoriasis	0.00218	0.00218	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—psoriasis	0.00218	0.00218	CcSEcCtD
Vildagliptin—Asthenia—Calcitriol—psoriasis	0.00216	0.00216	CcSEcCtD
Vildagliptin—Malnutrition—Mycophenolic acid—psoriasis	0.00216	0.00216	CcSEcCtD
Vildagliptin—Urticaria—Acitretin—psoriasis	0.00213	0.00213	CcSEcCtD
Vildagliptin—Flatulence—Mycophenolic acid—psoriasis	0.00212	0.00212	CcSEcCtD
Vildagliptin—Headache—Methoxsalen—psoriasis	0.00211	0.00211	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Cyclosporine—psoriasis	0.00211	0.00211	CcSEcCtD
Vildagliptin—Skin exfoliation—Methotrexate—psoriasis	0.00211	0.00211	CcSEcCtD
Vildagliptin—Oedema—Hydroxyurea—psoriasis	0.0021	0.0021	CcSEcCtD
Vildagliptin—Infection—Hydroxyurea—psoriasis	0.00209	0.00209	CcSEcCtD
Vildagliptin—Weight increased—Prednisolone—psoriasis	0.00207	0.00207	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Hydrocortisone—psoriasis	0.00207	0.00207	CcSEcCtD
Vildagliptin—Nervous system disorder—Hydroxyurea—psoriasis	0.00206	0.00206	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Mycophenolate mofetil—psoriasis	0.00206	0.00206	CcSEcCtD
Vildagliptin—Diarrhoea—Calcitriol—psoriasis	0.00206	0.00206	CcSEcCtD
Vildagliptin—Pancreatitis—Triamcinolone—psoriasis	0.00205	0.00205	CcSEcCtD
Vildagliptin—Skin disorder—Hydroxyurea—psoriasis	0.00204	0.00204	CcSEcCtD
Vildagliptin—Weight increased—Hydrocortisone—psoriasis	0.00202	0.00202	CcSEcCtD
Vildagliptin—Tremor—Mycophenolic acid—psoriasis	0.00202	0.00202	CcSEcCtD
Vildagliptin—Nausea—Methoxsalen—psoriasis	0.002	0.002	CcSEcCtD
Vildagliptin—Hepatitis—Cyclosporine—psoriasis	0.002	0.002	CcSEcCtD
Vildagliptin—Infestation NOS—Hydrocortisone—psoriasis	0.00198	0.00198	CcSEcCtD
Vildagliptin—Infestation—Hydrocortisone—psoriasis	0.00198	0.00198	CcSEcCtD
Vildagliptin—Connective tissue disorder—Cyclosporine—psoriasis	0.00197	0.00197	CcSEcCtD
Vildagliptin—Hepatitis—Mycophenolate mofetil—psoriasis	0.00195	0.00195	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Triamcinolone—psoriasis	0.00195	0.00195	CcSEcCtD
Vildagliptin—Oedema peripheral—Mycophenolate mofetil—psoriasis	0.00193	0.00193	CcSEcCtD
Vildagliptin—Connective tissue disorder—Mycophenolate mofetil—psoriasis	0.00192	0.00192	CcSEcCtD
Vildagliptin—Asthenia—Acitretin—psoriasis	0.00192	0.00192	CcSEcCtD
Vildagliptin—Weight increased—Triamcinolone—psoriasis	0.00191	0.00191	CcSEcCtD
Vildagliptin—Headache—Calcitriol—psoriasis	0.00188	0.00188	CcSEcCtD
Vildagliptin—Arthralgia—Mycophenolic acid—psoriasis	0.00184	0.00184	CcSEcCtD
Vildagliptin—Diarrhoea—Acitretin—psoriasis	0.00183	0.00183	CcSEcCtD
Vildagliptin—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.00183	0.00183	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—psoriasis	0.00182	0.00182	CcSEcCtD
Vildagliptin—Angiopathy—Cyclosporine—psoriasis	0.00182	0.00182	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.00181	0.00181	CcSEcCtD
Vildagliptin—Fatigue—Hydroxyurea—psoriasis	0.00181	0.00181	CcSEcCtD
Vildagliptin—Chills—Cyclosporine—psoriasis	0.0018	0.0018	CcSEcCtD
Vildagliptin—Constipation—Hydroxyurea—psoriasis	0.0018	0.0018	CcSEcCtD
Vildagliptin—Nausea—Calcitriol—psoriasis	0.00179	0.00179	CcSEcCtD
Vildagliptin—Angiopathy—Mycophenolate mofetil—psoriasis	0.00177	0.00177	CcSEcCtD
Vildagliptin—Dizziness—Acitretin—psoriasis	0.00177	0.00177	CcSEcCtD
Vildagliptin—Dizziness—Fluocinolone Acetonide—psoriasis	0.00176	0.00176	CcSEcCtD
Vildagliptin—Oedema—Mycophenolic acid—psoriasis	0.00176	0.00176	CcSEcCtD
Vildagliptin—Chills—Mycophenolate mofetil—psoriasis	0.00175	0.00175	CcSEcCtD
Vildagliptin—Connective tissue disorder—Hydrocortisone—psoriasis	0.00175	0.00175	CcSEcCtD
Vildagliptin—Infection—Mycophenolic acid—psoriasis	0.00175	0.00175	CcSEcCtD
Vildagliptin—Malnutrition—Cyclosporine—psoriasis	0.00174	0.00174	CcSEcCtD
Vildagliptin—Weight increased—Betamethasone—psoriasis	0.00173	0.00173	CcSEcCtD
Vildagliptin—Weight increased—Dexamethasone—psoriasis	0.00173	0.00173	CcSEcCtD
Vildagliptin—Nervous system disorder—Mycophenolic acid—psoriasis	0.00173	0.00173	CcSEcCtD
Vildagliptin—Flatulence—Cyclosporine—psoriasis	0.00172	0.00172	CcSEcCtD
Vildagliptin—Skin disorder—Mycophenolic acid—psoriasis	0.00171	0.00171	CcSEcCtD
Vildagliptin—Malnutrition—Mycophenolate mofetil—psoriasis	0.0017	0.0017	CcSEcCtD
Vildagliptin—Hyperhidrosis—Mycophenolic acid—psoriasis	0.0017	0.0017	CcSEcCtD
Vildagliptin—Flatulence—Mycophenolate mofetil—psoriasis	0.00168	0.00168	CcSEcCtD
Vildagliptin—Headache—Acitretin—psoriasis	0.00168	0.00168	CcSEcCtD
Vildagliptin—Headache—Fluocinolone Acetonide—psoriasis	0.00167	0.00167	CcSEcCtD
Vildagliptin—Tremor—Cyclosporine—psoriasis	0.00163	0.00163	CcSEcCtD
Vildagliptin—Pancreatitis—Prednisone—psoriasis	0.00162	0.00162	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Mycophenolic acid—psoriasis	0.0016	0.0016	CcSEcCtD
Vildagliptin—Tremor—Mycophenolate mofetil—psoriasis	0.00159	0.00159	CcSEcCtD
Vildagliptin—Angioedema—Cyclosporine—psoriasis	0.00159	0.00159	CcSEcCtD
Vildagliptin—Nausea—Acitretin—psoriasis	0.00159	0.00159	CcSEcCtD
Vildagliptin—Nausea—Fluocinolone Acetonide—psoriasis	0.00159	0.00159	CcSEcCtD
Vildagliptin—Angioedema—Mycophenolate mofetil—psoriasis	0.00155	0.00155	CcSEcCtD
Vildagliptin—Malnutrition—Hydrocortisone—psoriasis	0.00155	0.00155	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.00152	0.00152	CcSEcCtD
Vildagliptin—Fatigue—Mycophenolic acid—psoriasis	0.00152	0.00152	CcSEcCtD
Vildagliptin—Asthenia—Hydroxyurea—psoriasis	0.00151	0.00151	CcSEcCtD
Vildagliptin—Weight increased—Prednisone—psoriasis	0.00151	0.00151	CcSEcCtD
Vildagliptin—Constipation—Mycophenolic acid—psoriasis	0.0015	0.0015	CcSEcCtD
Vildagliptin—Arthralgia—Cyclosporine—psoriasis	0.00149	0.00149	CcSEcCtD
Vildagliptin—Liver function test abnormal—Methotrexate—psoriasis	0.00148	0.00148	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.00147	0.00147	CcSEcCtD
Vildagliptin—Angioedema—Prednisolone—psoriasis	0.00145	0.00145	CcSEcCtD
Vildagliptin—Arthralgia—Mycophenolate mofetil—psoriasis	0.00145	0.00145	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.00144	0.00144	CcSEcCtD
Vildagliptin—Diarrhoea—Hydroxyurea—psoriasis	0.00144	0.00144	CcSEcCtD
Vildagliptin—Oedema—Cyclosporine—psoriasis	0.00142	0.00142	CcSEcCtD
Vildagliptin—Angioedema—Hydrocortisone—psoriasis	0.00142	0.00142	CcSEcCtD
Vildagliptin—Infection—Cyclosporine—psoriasis	0.00141	0.00141	CcSEcCtD
Vildagliptin—Nervous system disorder—Cyclosporine—psoriasis	0.0014	0.0014	CcSEcCtD
Vildagliptin—Dizziness—Hydroxyurea—psoriasis	0.00139	0.00139	CcSEcCtD
Vildagliptin—Oedema—Mycophenolate mofetil—psoriasis	0.00139	0.00139	CcSEcCtD
Vildagliptin—Skin disorder—Cyclosporine—psoriasis	0.00138	0.00138	CcSEcCtD
Vildagliptin—Angiopathy—Dexamethasone—psoriasis	0.00138	0.00138	CcSEcCtD
Vildagliptin—Angiopathy—Betamethasone—psoriasis	0.00138	0.00138	CcSEcCtD
Vildagliptin—Infection—Mycophenolate mofetil—psoriasis	0.00138	0.00138	CcSEcCtD
Vildagliptin—Hyperhidrosis—Cyclosporine—psoriasis	0.00138	0.00138	CcSEcCtD
Vildagliptin—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.00136	0.00136	CcSEcCtD
Vildagliptin—Pancreatitis—Methotrexate—psoriasis	0.00136	0.00136	CcSEcCtD
Vildagliptin—Skin disorder—Mycophenolate mofetil—psoriasis	0.00135	0.00135	CcSEcCtD
Vildagliptin—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.00134	0.00134	CcSEcCtD
Vildagliptin—Angioedema—Triamcinolone—psoriasis	0.00133	0.00133	CcSEcCtD
Vildagliptin—Headache—Hydroxyurea—psoriasis	0.00132	0.00132	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.00131	0.00131	CcSEcCtD
Vildagliptin—Connective tissue disorder—Prednisone—psoriasis	0.0013	0.0013	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.0013	0.0013	CcSEcCtD
Vildagliptin—Oedema—Prednisolone—psoriasis	0.0013	0.0013	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Methotrexate—psoriasis	0.00129	0.00129	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.00127	0.00127	CcSEcCtD
Vildagliptin—Oedema—Hydrocortisone—psoriasis	0.00127	0.00127	CcSEcCtD
Vildagliptin—Asthenia—Mycophenolic acid—psoriasis	0.00126	0.00126	CcSEcCtD
Vildagliptin—Infection—Hydrocortisone—psoriasis	0.00126	0.00126	CcSEcCtD
Vildagliptin—Hyperhidrosis—Prednisolone—psoriasis	0.00125	0.00125	CcSEcCtD
Vildagliptin—Nausea—Hydroxyurea—psoriasis	0.00125	0.00125	CcSEcCtD
Vildagliptin—Nervous system disorder—Hydrocortisone—psoriasis	0.00124	0.00124	CcSEcCtD
Vildagliptin—Infestation NOS—Methotrexate—psoriasis	0.00123	0.00123	CcSEcCtD
Vildagliptin—Infestation—Methotrexate—psoriasis	0.00123	0.00123	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Cyclosporine—psoriasis	0.00123	0.00123	CcSEcCtD
Vildagliptin—Skin disorder—Hydrocortisone—psoriasis	0.00123	0.00123	CcSEcCtD
Vildagliptin—Fatigue—Cyclosporine—psoriasis	0.00123	0.00123	CcSEcCtD
Vildagliptin—Hyperhidrosis—Hydrocortisone—psoriasis	0.00122	0.00122	CcSEcCtD
Vildagliptin—Constipation—Cyclosporine—psoriasis	0.00122	0.00122	CcSEcCtD
Vildagliptin—Angioedema—Betamethasone—psoriasis	0.00121	0.00121	CcSEcCtD
Vildagliptin—Angioedema—Dexamethasone—psoriasis	0.00121	0.00121	CcSEcCtD
Vildagliptin—Diarrhoea—Mycophenolic acid—psoriasis	0.0012	0.0012	CcSEcCtD
Vildagliptin—Angiopathy—Prednisone—psoriasis	0.0012	0.0012	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.0012	0.0012	CcSEcCtD
Vildagliptin—Oedema—Triamcinolone—psoriasis	0.00119	0.00119	CcSEcCtD
Vildagliptin—Constipation—Mycophenolate mofetil—psoriasis	0.00119	0.00119	CcSEcCtD
Vildagliptin—Infection—Triamcinolone—psoriasis	0.00118	0.00118	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Methotrexate—psoriasis	0.00117	0.00117	CcSEcCtD
Vildagliptin—Dizziness—Mycophenolic acid—psoriasis	0.00116	0.00116	CcSEcCtD
Vildagliptin—Malnutrition—Prednisone—psoriasis	0.00115	0.00115	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.00115	0.00115	CcSEcCtD
Vildagliptin—Hyperhidrosis—Triamcinolone—psoriasis	0.00115	0.00115	CcSEcCtD
Vildagliptin—Urticaria—Cyclosporine—psoriasis	0.00113	0.00113	CcSEcCtD
Vildagliptin—Hepatitis—Methotrexate—psoriasis	0.00111	0.00111	CcSEcCtD
Vildagliptin—Urticaria—Mycophenolate mofetil—psoriasis	0.0011	0.0011	CcSEcCtD
Vildagliptin—Headache—Mycophenolic acid—psoriasis	0.0011	0.0011	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.00109	0.00109	CcSEcCtD
Vildagliptin—Fatigue—Hydrocortisone—psoriasis	0.00109	0.00109	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.00109	0.00109	CcSEcCtD
Vildagliptin—Oedema—Betamethasone—psoriasis	0.00108	0.00108	CcSEcCtD
Vildagliptin—Oedema—Dexamethasone—psoriasis	0.00108	0.00108	CcSEcCtD
Vildagliptin—Infection—Betamethasone—psoriasis	0.00107	0.00107	CcSEcCtD
Vildagliptin—Infection—Dexamethasone—psoriasis	0.00107	0.00107	CcSEcCtD
Vildagliptin—Nervous system disorder—Dexamethasone—psoriasis	0.00106	0.00106	CcSEcCtD
Vildagliptin—Nervous system disorder—Betamethasone—psoriasis	0.00106	0.00106	CcSEcCtD
Vildagliptin—Angioedema—Prednisone—psoriasis	0.00105	0.00105	CcSEcCtD
Vildagliptin—Nausea—Mycophenolic acid—psoriasis	0.00105	0.00105	CcSEcCtD
Vildagliptin—Hyperhidrosis—Betamethasone—psoriasis	0.00105	0.00105	CcSEcCtD
Vildagliptin—Hyperhidrosis—Dexamethasone—psoriasis	0.00105	0.00105	CcSEcCtD
Vildagliptin—Urticaria—Prednisolone—psoriasis	0.00103	0.00103	CcSEcCtD
Vildagliptin—Fatigue—Triamcinolone—psoriasis	0.00103	0.00103	CcSEcCtD
Vildagliptin—Asthenia—Cyclosporine—psoriasis	0.00102	0.00102	CcSEcCtD
Vildagliptin—Urticaria—Hydrocortisone—psoriasis	0.00101	0.00101	CcSEcCtD
Vildagliptin—Angiopathy—Methotrexate—psoriasis	0.001	0.001	CcSEcCtD
Vildagliptin—Asthenia—Mycophenolate mofetil—psoriasis	0.000996	0.000996	CcSEcCtD
Vildagliptin—Chills—Methotrexate—psoriasis	0.000994	0.000994	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000985	0.000985	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000985	0.000985	CcSEcCtD
Vildagliptin—Arthralgia—Prednisone—psoriasis	0.000982	0.000982	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000975	0.000975	CcSEcCtD
Vildagliptin—Diarrhoea—Cyclosporine—psoriasis	0.000974	0.000974	CcSEcCtD
Vildagliptin—Malnutrition—Methotrexate—psoriasis	0.000964	0.000964	CcSEcCtD
Vildagliptin—Diarrhoea—Mycophenolate mofetil—psoriasis	0.00095	0.00095	CcSEcCtD
Vildagliptin—Urticaria—Triamcinolone—psoriasis	0.000946	0.000946	CcSEcCtD
Vildagliptin—Dizziness—Cyclosporine—psoriasis	0.000941	0.000941	CcSEcCtD
Vildagliptin—Oedema—Prednisone—psoriasis	0.000941	0.000941	CcSEcCtD
Vildagliptin—Infection—Prednisone—psoriasis	0.000935	0.000935	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000933	0.000933	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Betamethasone—psoriasis	0.000933	0.000933	CcSEcCtD
Vildagliptin—Fatigue—Betamethasone—psoriasis	0.000932	0.000932	CcSEcCtD
Vildagliptin—Fatigue—Dexamethasone—psoriasis	0.000932	0.000932	CcSEcCtD
Vildagliptin—Nervous system disorder—Prednisone—psoriasis	0.000923	0.000923	CcSEcCtD
Vildagliptin—Dizziness—Mycophenolate mofetil—psoriasis	0.000918	0.000918	CcSEcCtD
Vildagliptin—Skin disorder—Prednisone—psoriasis	0.000914	0.000914	CcSEcCtD
Vildagliptin—Hyperhidrosis—Prednisone—psoriasis	0.00091	0.00091	CcSEcCtD
Vildagliptin—Asthenia—Hydrocortisone—psoriasis	0.000908	0.000908	CcSEcCtD
Vildagliptin—Headache—Cyclosporine—psoriasis	0.000892	0.000892	CcSEcCtD
Vildagliptin—Headache—Mycophenolate mofetil—psoriasis	0.00087	0.00087	CcSEcCtD
Vildagliptin—Diarrhoea—Hydrocortisone—psoriasis	0.000866	0.000866	CcSEcCtD
Vildagliptin—Urticaria—Dexamethasone—psoriasis	0.000859	0.000859	CcSEcCtD
Vildagliptin—Urticaria—Betamethasone—psoriasis	0.000859	0.000859	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Prednisone—psoriasis	0.000858	0.000858	CcSEcCtD
Vildagliptin—Dizziness—Prednisolone—psoriasis	0.000857	0.000857	CcSEcCtD
Vildagliptin—Asthenia—Triamcinolone—psoriasis	0.000855	0.000855	CcSEcCtD
Vildagliptin—Nausea—Cyclosporine—psoriasis	0.000846	0.000846	CcSEcCtD
Vildagliptin—Dizziness—Hydrocortisone—psoriasis	0.000837	0.000837	CcSEcCtD
Vildagliptin—Nausea—Mycophenolate mofetil—psoriasis	0.000825	0.000825	CcSEcCtD
Vildagliptin—Arthralgia—Methotrexate—psoriasis	0.000821	0.000821	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000815	0.000815	CcSEcCtD
Vildagliptin—Fatigue—Prednisone—psoriasis	0.000812	0.000812	CcSEcCtD
Vildagliptin—Headache—Prednisolone—psoriasis	0.000812	0.000812	CcSEcCtD
Vildagliptin—Constipation—Prednisone—psoriasis	0.000805	0.000805	CcSEcCtD
Vildagliptin—Headache—Hydrocortisone—psoriasis	0.000793	0.000793	CcSEcCtD
Vildagliptin—Dizziness—Triamcinolone—psoriasis	0.000788	0.000788	CcSEcCtD
Vildagliptin—Infection—Methotrexate—psoriasis	0.000782	0.000782	CcSEcCtD
Vildagliptin—Asthenia—Dexamethasone—psoriasis	0.000776	0.000776	CcSEcCtD
Vildagliptin—Asthenia—Betamethasone—psoriasis	0.000776	0.000776	CcSEcCtD
Vildagliptin—Nervous system disorder—Methotrexate—psoriasis	0.000772	0.000772	CcSEcCtD
Vildagliptin—Nausea—Prednisolone—psoriasis	0.00077	0.00077	CcSEcCtD
Vildagliptin—Skin disorder—Methotrexate—psoriasis	0.000764	0.000764	CcSEcCtD
Vildagliptin—Hyperhidrosis—Methotrexate—psoriasis	0.000761	0.000761	CcSEcCtD
Vildagliptin—Nausea—Hydrocortisone—psoriasis	0.000752	0.000752	CcSEcCtD
Vildagliptin—Urticaria—Prednisone—psoriasis	0.000748	0.000748	CcSEcCtD
Vildagliptin—Headache—Triamcinolone—psoriasis	0.000746	0.000746	CcSEcCtD
Vildagliptin—Diarrhoea—Dexamethasone—psoriasis	0.00074	0.00074	CcSEcCtD
Vildagliptin—Diarrhoea—Betamethasone—psoriasis	0.00074	0.00074	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000717	0.000717	CcSEcCtD
Vildagliptin—Dizziness—Betamethasone—psoriasis	0.000715	0.000715	CcSEcCtD
Vildagliptin—Dizziness—Dexamethasone—psoriasis	0.000715	0.000715	CcSEcCtD
Vildagliptin—Nausea—Triamcinolone—psoriasis	0.000708	0.000708	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Methotrexate—psoriasis	0.000679	0.000679	CcSEcCtD
Vildagliptin—Fatigue—Methotrexate—psoriasis	0.000678	0.000678	CcSEcCtD
Vildagliptin—Headache—Dexamethasone—psoriasis	0.000677	0.000677	CcSEcCtD
Vildagliptin—Headache—Betamethasone—psoriasis	0.000677	0.000677	CcSEcCtD
Vildagliptin—Asthenia—Prednisone—psoriasis	0.000675	0.000675	CcSEcCtD
Vildagliptin—Diarrhoea—Prednisone—psoriasis	0.000644	0.000644	CcSEcCtD
Vildagliptin—Nausea—Betamethasone—psoriasis	0.000642	0.000642	CcSEcCtD
Vildagliptin—Nausea—Dexamethasone—psoriasis	0.000642	0.000642	CcSEcCtD
Vildagliptin—Urticaria—Methotrexate—psoriasis	0.000625	0.000625	CcSEcCtD
Vildagliptin—Dizziness—Prednisone—psoriasis	0.000623	0.000623	CcSEcCtD
Vildagliptin—Headache—Prednisone—psoriasis	0.00059	0.00059	CcSEcCtD
Vildagliptin—Asthenia—Methotrexate—psoriasis	0.000564	0.000564	CcSEcCtD
Vildagliptin—Nausea—Prednisone—psoriasis	0.000559	0.000559	CcSEcCtD
Vildagliptin—Diarrhoea—Methotrexate—psoriasis	0.000538	0.000538	CcSEcCtD
Vildagliptin—Dizziness—Methotrexate—psoriasis	0.00052	0.00052	CcSEcCtD
Vildagliptin—Headache—Methotrexate—psoriasis	0.000493	0.000493	CcSEcCtD
Vildagliptin—Nausea—Methotrexate—psoriasis	0.000467	0.000467	CcSEcCtD
